Antimicrobial Susceptibility Testing Market
The global antimicrobial susceptibility testing market is forecast to grow at a compound annual growth rate (CAGR) of more than 6% during the forecast period from 2021-2030.
AST stands for antimicrobial susceptibility testing, a procedure performed in a laboratory to confirm the antibiotic appropriate for a particular patient, based on the infection type and the type of bacteria causing the infection. Therefore, one can determine a microbe’s sensitivity to any given antibiotic through the use of this test. In order to achieve successful treatment, it has been important not to over-medicate since this can lead to paradoxical worsening.
Request To Download Free Sample of This Strategic Report @https://reportocean.com/industry-verticals/sample-request?report_id=BWCC616
Factors Affecting
- The use of antimicrobial susceptibility testing kits has increased over the last decade due to the rising prevalence of infectious diseases. The need for antibiotic susceptibility testing (ASTs) has become evident to medical practitioners, who are now required to perform these tests as part of clinical microbiology laboratories. It is likely to stimulate the market for ASTs.
- Antibiotic misuse and overuse are causing an increase in antimicrobial resistance (AMR), and antimicrobial susceptibility testing is being used more and more by biopharmaceutical and pharmaceutical companies leading to significant growth of the antimicrobial susceptibility testing market.
- Increasing hospital-acquired infections (HAIs), an increase in patient populations (particularly in developing countries), and an increasing awareness of the threat of antimicrobial resistance are likely to fuel market growth.
- There is an emerging opportunity for key players of the antimicrobial susceptibility testing market to invest in the market due to the availability of various manual and automated products with faster results and higher accuracy. As a result, the market will continue to expand and offer significant growth prospects over the forecast period.
Impact Analysis of COVID-19
COVID-19 has caused problems in a number of industries, including the global antimicrobial susceptibility testing market. The use of automated antimicrobial susceptibility testing devices such as the Accelerate Pheno system, MicroScan WalkAway, and Sensitive ARIS system decreased significantly during the Pandemic due to hospitals’ focus on COVID -19 management. In addition, all other procedures and protocols have ceased temporarily to ensure that the COVID-19 virus does not spread. Also, lockdown and curfew regulations had a negative impact on antimicrobial susceptibility testing.
Regional Analysis
The North American market for antimicrobial susceptibility testing dominates the global market. North America’s market is growing due to the increasing investments in research and development of new automated AST systems, technological advancements in antimicrobial susceptibility products, and the rising prevalence of infectious diseases.
Leading Companies
The leading prominent competitors in the global antimicrobial susceptibility testing market are:
- Accelerate Diagnostics, Inc. (U.S.)
- Becton, Dickinson, and Company (U.S.)
- BioMérieux SA (France)
- Bio-Rad Laboratories, Inc. (U.S.)
- Biotron Ltd (Australia)
- Creative Diagnostics (U.S.)
- Danaher Corporation (U.S.)
- ELITechGroup (France)
- Genefluidics, Inc. (U.S.)
- Hi-Media Laboratories (India)
- InvivoGen (U.S.)
- Liofilchem S.r.l. (Europe)
- Merck KGaA (Europe)
- MP Biomedicals (U.S.)
- PML Microbiologicals Inc. (U.S.)
- QuantaMatrix Inc. (South Korea)
- Roche Diagnostics Limited (Europe)
- Thermo Fisher Scientific (U.S.)
- Zhuhai DL Biotech Co. Ltd. (China)
- Other Prominent Players
Scope of the Report
The global antimicrobial susceptibility testing market segmentation focuses on Type, Method, Application, Product, End-User, and Region.
Segmentation based on Type
- Antibacterial Susceptibility Testing
- Antifungal Susceptibility Testing
- Antiparasitic Susceptibility Testing
- Other Susceptibility Testing Types (slow-growing pathogens)
Segmentation based on Method
- Etest Method
- Disk Diffusion
- Automated Susceptibility Testing Instruments
- Agar Dilution
- Genotyping Methods
Segmentation based on Application
- Clinical Diagnostics
- Drug Discovery and Development
- Epidemiology
- Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring)
Segmentation based on Product
- Manual Antimicrobial Susceptibility Testing Products
- Susceptibility Testing Disks
- MIC Strips
- Susceptibility Testing Plates
- Automated Laboratory Instruments
- Culture and Growth Media
- Consumables
Segmentation based on End-User
- Hospitals and Diagnostic Centers
- Pharmaceutical and Biotechnology Companies
- Research &Academic Institutes
- Clinical Research Organizations (CROs)
Segmentation based on Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- Western Europe
- The UK
- Germany
- France
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Poland
- Russia
- Rest of Eastern Europe
- Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- UAE
- Saudi Arabia
- South Africa
- Rest of MEA
- South America
- Brazil
- Argentina
- Rest of South America
Table of Content
Chapter 1: Global Antimicrobial Susceptibility Testing Industry Overview
Chapter 3: Market Dynamics
Chapter 4: Top Company Profiles
Chapter 5: Global Antimicrobial Susceptibility Testing market Competition, by Players
Chapter 6: Global Market Size by Regions
Chapter 7: Global Market Segment by Application
Chapter 8: Global Antimicrobial Susceptibility Testing Industry Segment by Type
Chapter 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Chapter 10: Strategies and key policies by Distributors/Suppliers/Traders
Chapter 11: Key Marketing Strategy Analysis, by Market Vendors
Chapter 12: Market Effect Factors Analysis
Chapter 13: Global Antimicrobial Susceptibility Testing market Size Forecast (2023-2032).
Continue….
Reasons to Buy This Report
(A) The research provides valuable insights for top administration, policymakers, professionals, product advancements, sales managers, and stakeholders in the market. It helps them make informed decisions and strategize effectively.
(B) The report offers comprehensive analysis of Antimicrobial Susceptibility Testing market revenues on a global, regional, and country level, projecting trends until 2032. This data allows companies to assess their market share, identify growth opportunities, and explore new markets.
(C) The research includes segmentation of the Antimicrobial Susceptibility Testing market based on types, applications, technologies, and end-uses. This segmentation enables leaders to plan their products and allocate resources based on the expected growth rates of each segment.
(D) Analysis of the Antimicrobial Susceptibility Testing market benefits investors by providing insights into market scope, position, key drivers, challenges, restraints, expansion opportunities, and potential threats. This information helps them make informed investment decisions.
(E) The report offers a detailed analysis of competitors, their key strategies, and market positioning. This knowledge allows businesses to better understand the competition and plan their own strategies accordingly.
(F) The study helps evaluate Antimicrobial Susceptibility Testing business predictions by region, key countries, and top companies, providing valuable information for investment planning and decision-making.
About Report Ocean:
Report Ocean is a renowned provider of market research reports, offering high-quality insights to clients in various industries. Their goal is to assist clients in achieving their top line and bottom line objectives, thereby enhancing their market share in today’s competitive environment. As a trusted source for innovative market research reports, Report Ocean serves as a comprehensive solution for individuals, organizations, and industries seeking valuable market intelligence.